Qube Research & Technologies LTD Nautilus Biotechnology, Inc. Transaction History
Qube Research & Technologies LTD
- $93.8 Billion
- Q2 2025
A detailed history of Qube Research & Technologies LTD transactions in Nautilus Biotechnology, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 62,138 shares of NAUT stock, worth $106,877. This represents 0.0% of its overall portfolio holdings.
Number of Shares
62,138Holding current value
$106,877% of portfolio
0.0%Shares
4 transactions
Others Institutions Holding NAUT
# of Institutions
75Shares Held
62.9MCall Options Held
158KPut Options Held
0-
Ah Equity Partners Bio Ii, L.L.C. Menlo Park, CA16.3MShares$28 Million24.08% of portfolio
-
Perceptive Advisors LLC New York, NY12.6MShares$21.7 Million0.4% of portfolio
-
Cercano Management LLC Bellevue, WA7.17MShares$12.3 Million0.16% of portfolio
-
Madrona Venture Group, LLC6.02MShares$10.4 Million36.76% of portfolio
-
Black Rock Inc. New York, NY3.83MShares$6.58 Million0.0% of portfolio
About Nautilus Biotechnology, Inc.
- Ticker NAUT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,663,000
- Market Cap $214M
- Description
- Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...